Live Breaking News & Updates on Imetelstat Efficacy

Stay updated with breaking news from Imetelstat efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Efficacy of Imetelstat in Achieving Red Blood Cell Transfusion Independence (RBC-TI) across Different Risk Subgroups in Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Relapsed/Refractory (R/R) to Erythropoiesis-Stimulating Agents (ESAs) in IMerge Phase 3 Study

Amer Zeidan, MBBS, MHS, presents data from the IMerge phase 3 study on the efficacy of imetelstat in achieving red blood cell transfusion independence across different risk subgroups in patients with lower-risk myelodysplastic syndromes relapsed/refractory to erythropoiesis-stimulating agents. ....

San Diego , United States , Samer Zeidan , International Prognostic Scoring System , Achieving Red Blood Cell Transfusion Independence , Different Risk Subgroups , Lower Risk Myelodysplastic Syndromes , Erythropoiesis Stimulating Agents , Partnership With , Myelodysplastic Syndrome , Imerge Study , Imerge Trial , Imerge Phase 3 Study , Lower Risk Mds , Lower Risk Myelodysplastic Syndrome , Red Blood Cell Transfusion Independence , Asco 2023 , Imetelstat Efficacy ,